Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9270856 | Journal of Infection | 2005 | 5 Pages |
Abstract
The efficacy of oral telithromycin 800Â mg once daily for 7 days was evaluated in a multicentre, multinational study in patients with community-acquired pneumonia caused by Streptococcus pneumoniae resistant to penicillin and/or erythromycin. Per-protocol clinical and bacteriological outcomes were assessed 10-17 days post-therapy. Of the 129 patients with S. pneumoniae infection, 16 were infected with strains resistant to penicillin and/or erythromycin. Fifteen of these 16 patients (93.8%) were assessed as clinically and bacteriologically cured at the post-therapy visit.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Dirkie van Rensburg, Charles Fogarty, MarÃa Cristina De Salvo, Manickam Rangaraju, Roomi Nusrat,